Type 1 Diabetes: Advances in Research and Management

Type 1 diabetes results from autoimmune destruction of pancreatic beta cells, necessitating lifelong insulin therapy for glycemic control. Recent advances in type 1 diabetes research focus on elucidating the immunopathogenesis of the disease and developing immunomodulatory therapies aimed at halting or delaying beta cell destruction. Innovations in insulin delivery systems, such as closed-loop systems or beta cell replacement therapies, aim to improve glycemic control and enhance quality of life for individuals with type 1 diabetes. Patient-centered care models emphasize individualized management strategies tailored to lifestyle preferences and treatment goals, highlighting the importance of multidisciplinary diabetes care teams in optimizing outcomes for individuals with type 1 diabetes.

    Related Conference of Type 1 Diabetes: Advances in Research and Management

    May 08-09, 2025

    5th European Endocrinology and Diabetes Congress

    Madrid, Spain
    May 19-20, 2025

    6th World Summit on Diabetes

    Rome, Italy
    June 04-05, 2025

    4th World Congress on Diabetes and Pediatric Endocrinology

    Edinburgh, Scotland
    July 29-30, 2025

    15th World Congress on Endocrinology and Diabetes

    Paris, France
    September 08-09, 2025

    3rd World congress and Expo on Diabetes

    Frankfurt, Germany
    October 30-31, 2025

    5th Annual Summit on Diabetes and Endocrinology

    Paris, France
    November 06-07, 2025

    8th Annual Meeting on Diabetes and Endocrinology

    Dubai, UAE
    November 20-21, 2025

    21st World Congress on Endocrinology & Diabetes

    Paris, France
    March 26-27, 2026

    7th Global summit on Diabetes and Endocrinology

    Amsterdam, Netherlands

    Type 1 Diabetes: Advances in Research and Management Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in